BSE filing, NSE: ABDL. Summary written from the filing by ALFA Finder's alert engine.
Allied Blenders & Distillers Ltd: key numbers
- Share price
- ₹700.00
- Market cap
- ₹19,580 Cr
- Revenue (annual)
- ₹3,923 Cr
- Net profit (annual)
- ₹228.3 Cr
- P/E (TTM)
- 85.8×Sector 26.8×
- Promoter holding
- 78.95%-1.96% QoQ
- FII holding
- 4.40%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Allied Blenders & Distillers Ltd
All →Allied Blenders & Distillers Earnings Call Transcript: Key Takeaways
ABD achieved record quarterly volumes crossing 10 million cases, driven by aggressive premiumization and the turnaround of flagship brands in key Southern markets.
- Call
- Guides 15% growth
Allied Blenders & Distillers Investor Presentation: Key Takeaways
Q2FY27 revenue ₹1,152 Cr (+15.8%), EBITDA ₹143 Cr (+10.0%), margin 12.4% (-66 bps), PAT ₹69 Cr (+9.7%). Record 10.0 Mn case volume; premiumisation and P&A-led strategy.
Allied Blenders & Distillers Results Update
Allied Blenders reported Q2FY27 income from operations of ₹1,152 crore, up 15.8% YoY, with PAT of ₹69 crore. Record volumes and newly commissioned plants supported the growth.
Allied Blenders & Distillers Management Change
Allied Blenders re-appointed Balaji Swaminathan as Independent Director for five years from February 2027. The board also sought shareholder approval via postal ballot.
Allied Blenders & Distillers Q2 FY27 Results: Net Profit ₹69 Cr, Up 9.7% YoY
Allied Blenders & Distillers Ltd reported revenue from operations of ₹2,086 Cr (+6.8% YoY) and net profit of ₹69 Cr (+9.7% YoY) for Q2 FY27.
- Key figure
- Net profit ₹69 Cr · +9.7% YoY
Allied Blenders & Distillers ED Probe / Tax Survey
Allied Blenders and Distillers reported a DRI visit regarding an industry-wide HSN code review for bulk Scotch imports. The company confirms no material financial or operational impact.
Other board meeting date announcements
All →Jetking Infotrain Board Meeting Date
Jetking Infotrain has scheduled a board meeting on November 4, 2026 to consider unaudited quarterly and half-year results. The trading window remains closed until 48 hours after the results announcement.
Metropolis Healthcare Board Meeting Date
Metropolis Healthcare intimated a board meeting on November 3, 2026 to consider Q2 and half-year unaudited results and possible interim dividend. Trading window is closed October 1 to November 5, 2026.
Aelea Commodities Board Meeting Date
Aelea Commodities has scheduled a board meeting for 2 November 2026 to consider half-year results and other items. The agenda includes an additional independent director, a director resignation, and business expansion and capex.
R Systems International Board Meeting Date
R Systems International will hold a board meeting on 3 November 2026 to consider quarterly and nine-month results to September 2026. The trading window remains closed until 48 hours after the results are declared.
Onida Electronics Board Meeting Date
Onida Electronics schedules a 3 November 2026 board meeting for Q2 and half-year results and ESOP share allotment. Trading window stays closed until 48 hours post-results.
Platinum Industries Board Meeting Date
Platinum Industries Ltd intimated a board meeting on November 4, 2026 to approve unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026. Trading window closed from October 1, 2026.